9265.T
Yamashita Health Care Holdings,Inc. [9265.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
9265.T Stock Summary
Top 10 Correlated ETFs
9265.T
Top 10 Correlated Stocks
9265.T
In the News
9265.T Financial details
Company Rating
-
Market Cap
5.48B
Income
216M
Revenue
58.75B
Book val./share
3117.65
Cash/share
1384.71
Dividend
46
Dividend %
2.17%
Employees
570
Optionable
No
Shortable
Yes
Earnings
04 Jan 2024
P/E
25.1
Forward P/E
-
PEG
-3.65
P/S
0.09
P/B
0.68
P/C
1.53
P/FCF
-
Quick Ratio
1.02
Current Ratio
1.25
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
84.99
EPS next Y
-
EPS next Q
-
EPS this Y
-68.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.7%
Revenue last 5Y
-1.11%
Revenue Q/Q
-14.87%
EPS Q/Q
-25.6%
-
-
-
-
SMA20
5.54%
SMA50
5.96%
SMA100
3.5%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
3%
ROC
0.13%
Gross Margin
14%
Oper. Margin
2%
Profit Margin
-
Payout
-
Shs Outstand
2.55M
Shs Float
1.05M
-
-
-
-
Target Price
-
52W Range
1505.0-2285.0
52W High
-7.05%
52W Low
+41.13%
RSI
60
Rel Volume
0.21
Avg Volume
2.87K
Volume
600
Perf Week
0.71%
Perf Month
8.15%
Perf Quarter
3.06%
Perf Half Y
0.19%
-
-
-
-
Beta
0.421
-
-
Volatility
13.13%, 66.38%
Prev Close
-0.7%
Price
2124
Change
-0.05%
9265.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-05-31
| Metric | History | 2019-05-31 | 2020-05-31 | 2021-05-31 | 2022-05-31 | 2023-05-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 24.1K | 25.33K | 27.47K | 21.6K | 22.8K | |
| Net income per share | 56.57 | 180.07 | 265.77 | 272.67 | 85.79 | |
| Operating cash flow per share | -39.75 | 320.35 | 357.06 | 227.69 | 848.45 | |
| Free cash flow per share | -64.73 | 300.29 | 299.78 | 181.25 | 816.72 | |
| Cash per share | 784.41 | 1.02K | 1.27K | 1.38K | 2.12K | |
| Book value per share | 2.5K | 2.72K | 2.97K | 3.13K | 3.1K | |
| Tangible book value per share | 2.43K | 2.65K | 2.92K | 3.08K | 3.06K | |
| Share holders equity per share | 2.5K | 2.72K | 2.97K | 3.13K | 3.1K | |
| Interest debt per share | 1.32 | 0.96 | 1.64 | 1.51 | 0.78 | |
| Market cap | 3.07B | 4.98B | 5.12B | 4.94B | 5.12B | |
| Enterprise value | 738.2M | 1.96B | 1.47B | 969.2M | -706.46M | |
| P/E ratio | 21.28 | 10.82 | 7.55 | 7.1 | 23.37 | |
| Price to sales ratio | 0.05 | 0.08 | 0.07 | 0.09 | 0.09 | |
| POCF ratio | -30.29 | 6.08 | 5.62 | 8.51 | 2.36 | |
| PFCF ratio | -18.6 | 6.49 | 6.69 | 10.69 | 2.45 | |
| P/B Ratio | 0.48 | 0.72 | 0.68 | 0.62 | 0.65 | |
| PTB ratio | 0.48 | 0.72 | 0.68 | 0.62 | 0.65 | |
| EV to sales | 0.01 | 0.03 | 0.02 | 0.02 | -0.01 | |
| Enterprise value over EBITDA | 0.89 | 2.34 | 1.2 | 0.79 | -0.5 | |
| EV to operating cash flow | -7.28 | 2.4 | 1.61 | 1.67 | -0.33 | |
| EV to free cash flow | -4.47 | 2.56 | 1.92 | 2.09 | -0.34 | |
| Earnings yield | 0.05 | 0.09 | 0.13 | 0.14 | 0.04 | |
| Free cash flow yield | -0.05 | 0.15 | 0.15 | 0.09 | 0.41 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -2.81 | -3.59 | -2.97 | -3.23 | -4.13 | |
| Current ratio | 1.14 | 1.17 | 1.17 | 1.21 | 1.21 | |
| Interest coverage | 154.71 | 228.6 | 231.56 | 241.19 | 578 | |
| Income quality | -0.27 | 1.27 | 0.87 | 0.57 | 3.41 | |
| Dividend Yield | 0.02 | 0.02 | 0.03 | 0.05 | 0.04 | |
| Payout ratio | 0.46 | 0.23 | 0.2 | 0.33 | 0.95 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Capex to operating cash flow | 0.63 | -0.06 | -0.16 | -0.2 | -0.04 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.3 | -0.27 | -0.74 | -0.53 | -0.4 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.78K | 3.32K | 4.21K | 4.38K | 2.44K | |
| ROIC | 0.03 | 0.06 | 0.08 | 0.08 | 0.05 | |
| Return on tangible assets | 0.01 | 0.02 | 0.03 | 0.03 | 0.01 | |
| Graham Net | -1.21K | -1.14K | -1.14K | -890.27 | -754.93 | |
| Working capital | 1.89B | 2.34B | 2.74B | 3.24B | 3.38B | |
| Tangible asset value | 6.2B | 6.78B | 7.45B | 7.86B | 7.81B | |
| Net current asset value | 1.19B | 1.58B | 2.24B | 2.71B | 2.87B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 10.18B | 10.13B | 11.13B | 12.01B | 11.18B | |
| Average payables | 8.08B | 7.55B | 7.88B | 8.09B | 7.84B | |
| Average inventory | 2.4B | 2.62B | 2.85B | 2.83B | 2.82B | |
| Days sales outstanding | 60.14 | 57.19 | 63.16 | 78.69 | 65.71 | |
| Days payables outstanding | 50.63 | 47.1 | 48.33 | 60.78 | 56.72 | |
| Days of inventory on hand | 16.55 | 17.37 | 17.22 | 20.88 | 21.24 | |
| Receivables turnover | 6.07 | 6.38 | 5.78 | 4.64 | 5.55 | |
| Payables turnover | 7.21 | 7.75 | 7.55 | 6.01 | 6.43 | |
| Inventory turnover | 22.06 | 21.01 | 21.2 | 17.48 | 17.19 | |
| ROE | 0.02 | 0.07 | 0.09 | 0.09 | 0.03 | |
| Capex per share | -24.98 | -20.06 | -57.28 | -46.44 | -31.73 |
Quarterly Fundamentals Overview
Last date of statement is 2023-08-31 for Q1
| Metric | History | 2022-08-31 | 2022-11-30 | 2023-02-28 | 2023-05-31 | 2023-08-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 5.28K | 5.56K | 5.51K | 6.45K | 5.49K | |
| Net income per share | 64.63 | -143.37 | 79.13 | 85.39 | 63.46 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 574.25 | 709.78 | 1.28K | 2.12K | 1.38K | |
| Book value per share | 3.14K | 2.97K | 3.01K | 3.1K | 3.12K | |
| Tangible book value per share | 3.1K | 2.93K | 2.98K | 3.06K | 3.07K | |
| Share holders equity per share | 3.14K | 2.97K | 3.01K | 3.1K | 3.12K | |
| Interest debt per share | 0 | 0.39 | 0 | 0.39 | 6.66 | |
| Market cap | 4.16B | 4.13B | 4.56B | 5.12B | 4.96B | |
| Enterprise value | 2.7B | 2.32B | 1.29B | -706.46M | 1.44B | |
| P/E ratio | 6.3 | -2.82 | 5.64 | 5.87 | 7.65 | |
| Price to sales ratio | 0.31 | 0.29 | 0.32 | 0.31 | 0.35 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0.52 | 0.54 | 0.59 | 0.65 | 0.62 | |
| PTB ratio | 0.52 | 0.54 | 0.59 | 0.65 | 0.62 | |
| EV to sales | 0.2 | 0.16 | 0.09 | -0.04 | 0.1 | |
| Enterprise value over EBITDA | 9.8 | 6.61 | 4.13 | -2.61 | 6.72 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.04 | -0.09 | 0.04 | 0.04 | 0.03 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -5.33 | -5.16 | -10.47 | -21.49 | -16.44 | |
| Current ratio | 1.23 | 1.21 | 1.23 | 1.21 | 1.25 | |
| Interest coverage | 0 | 339 | 0 | 261 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0.09 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0.01 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.14K | 3.1K | 2.32K | 2.44K | 2.11K | |
| ROIC | 0.02 | 0.06 | 0.02 | 0.02 | 0.01 | |
| Return on tangible assets | 0.01 | -0.02 | 0.01 | 0.01 | 0.01 | |
| Graham Net | -905.05 | -1K | -706.06 | -754.93 | -618.32 | |
| Working capital | 3.3B | 3.06B | 3.3B | 3.38B | 3.53B | |
| Tangible asset value | 7.9B | 7.48B | 7.6B | 7.81B | 7.84B | |
| Net current asset value | 2.67B | 2.4B | 2.69B | 2.87B | 2.98B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 12.45B | 12.69B | 11.63B | 10.68B | 10.61B | |
| Average payables | 8.23B | 8.42B | 8.02B | 7.77B | 7.87B | |
| Average inventory | 2.8B | 3.06B | 3.16B | 3B | 2.9B | |
| Days sales outstanding | 86.97 | 78.43 | 69.68 | 57.25 | 68.99 | |
| Days payables outstanding | 66.25 | 60.68 | 57.68 | 49.64 | 58.85 | |
| Days of inventory on hand | 22.33 | 23.64 | 22.98 | 18.59 | 21.28 | |
| Receivables turnover | 1.03 | 1.15 | 1.29 | 1.57 | 1.3 | |
| Payables turnover | 1.36 | 1.48 | 1.56 | 1.81 | 1.53 | |
| Inventory turnover | 4.03 | 3.81 | 3.92 | 4.84 | 4.23 | |
| ROE | 0.02 | -0.05 | 0.03 | 0.03 | 0.02 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
9265.T Frequently Asked Questions
What is Yamashita Health Care Holdings,Inc. stock symbol ?
Yamashita Health Care Holdings,Inc. is a JP stock and trading under the symbol 9265.T
What is Yamashita Health Care Holdings,Inc. stock quote today ?
Yamashita Health Care Holdings,Inc. stock price is $2124 today.
Is Yamashita Health Care Holdings,Inc. stock public?
Yes, Yamashita Health Care Holdings,Inc. is a publicly traded company.
Company Profile
- Volume Average 2.87K
- Market Capitalization 5.48B
- Employee 570
- CEO Mr. Naoto Yamashita
- Headquarters Fukuoka City,JP
- IPO Date 2017-12-01
-
Website
https://www.yhchd.co.jp 
Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, shadowless lights, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, calculus crushing devices, and stents. It also provides consulting services related to the management of medical and long-term care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reception, posting agency for customer satisfaction surveys, and network security systems sales. The company was founded in 1926 and is headquartered in Fukuoka City, Japan.
